<DOC>
	<DOCNO>NCT00892918</DOCNO>
	<brief_summary>The purpose study determine whether difference corneal epithelial healing rate and/or toxicity follow pterygium excision , eye treat post-operatively moxifloxacin ( VIGAMOX ) versus gatifloxacin ( ZYMAR ) .</brief_summary>
	<brief_title>Effect Moxifloxacin Versus Gatifloxacin Corneal Epithelium Following Pterygium Excision</brief_title>
	<detailed_description />
	<mesh_term>Pterygium</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Gatifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>1. diagnosis primary pterygium clinical indication surgery 2. informed consent 1. know allergic reaction fluoroquinolones . 2. secondary\recurrent pterygium clinical suspect conjunctival tumor . 3. eye surgery last 6 month . 4. eye disorder : severe dry eye syndrome , ocular surface disease , glaucoma , recurrent corneal erosion , chronic corneal disease , chemical burn . 5. low compliance . 6. pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>pterygium</keyword>
	<keyword>gatifloxacin</keyword>
	<keyword>moxifloxacin</keyword>
	<keyword>corneal epithelial defect</keyword>
</DOC>